Study Stopped
Sponsor will not pursue CE mark for this product, which precludes need for large PMCF study.
Sponsor will not pursue CE mark for this product, which precludes need for large PMCF study.
N-Force
Sponsor study identifier
interventional
12
1 country
4
Study Start
February 21, 2019
Actual (reported)Primary Completion
March 11, 2021
Actual (reported)Study Completion
March 11, 2021
Actual (reported)The objective of this prospective study is to confirm safety and performance of N-Force Screws augmented with N-Force Blue applied in intracapsular proximal femur fracture treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 11, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 8, 2019
Actual (reported)January 16, 2019
Actual (reported)February 21, 2019
Actual (reported)March 11, 2021
Actual (reported)March 11, 2021
Actual (reported)June 8, 2022
Actual (reported)Number of Participants With a Reoperation
Reoperation after initial surgery to promote fracture healing, relieve pain, treat infection, or improve function.
12 months
Number of Participants With Radiographic Fracture Healing of the Intracapsular Femur (RUSH)
6 weeks, 3 months, 6 months, and 12 months
Participant Steinberg Classification at 12 Months
12 months
N-Force Screws augmented with N-Force Blue in Intracapsular Femur Fractures.
N-Force Fixation System 7.3 mm (Non-fenestrated/fenestrated) applied with washers; N-Force Blue (Bone Substitute Material)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Stanford University
Stanford, California, 94305, United States
Washington University
St Louis, Missouri, 63130, United States
Donald B Slocum Research and Education Foundation
Eugene, Oregon, 97401, United States
University of Utah
Salt Lake City, Utah, 84108, United States
Ryan Boylan, MBA
Zimmer Biomet
12 participants (actual enrollment reported by the registry).
First Submitted
January 8, 2019
First Posted
January 16, 2019
Study Start
February 21, 2019
Actual (reported)Average FIX-IT Score (Clinical Fracture Healing of the Intracapsular Femur)
6 weeks, 3 months, 6 months, and 12 months
Average EQ-5D-5L Score (Clinical Fracture Healing of the Intracapsular Femur)
6 weeks, 3 months, 6 months, and 12 months
Average Harris Hips Score (Clinical Fracture Healing of the Intracapsular Femur)
6 weeks, 3 months, 6 months, and 12 months
Contact the study team to confirm eligibility.
Primary Completion
March 11, 2021
Actual (reported)Study Completion
March 11, 2021
Actual (reported)Last Updated
June 8, 2022
Results First Posted
June 8, 2022
Record last verified: 2022-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: